Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Dekkers, Coco; Smits, Hidde; Stölzl, Dora; Spekhorst, Lotte; Knol, Edward; van Wijk, Femke; Harder, Inken; Werfel, Thomas; Schmitt, Jochen; Kleinheinz, Andreas; Abraham, Susanne; Thijs, Judith; Weidinger, Stephan; de Bruin-Weller, Marjolein; Bakker, Daphne; Drylewicz, Julia

doi:https://doi.org/10.1111/cea.14585

Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

DSpace/Manakin Repository

Type 2 Immune-Dominant Endotype Is Not Associated With Increased Responsiveness to Dupilumab Treatment in Adult Atopic Dermatitis Patients

Dekkers, Coco; Smits, Hidde; Stölzl, Dora; Spekhorst, Lotte; Knol, Edward; van Wijk, Femke; Harder, Inken; Werfel, Thomas; Schmitt, Jochen; Kleinheinz, Andreas; Abraham, Susanne; Thijs, Judith; Weidinger, Stephan; de Bruin-Weller, Marjolein; Bakker, Daphne; Drylewicz, Julia

(2025) Clinical and Experimental Allergy, volume 55, issue 1, pp. 97 - 99

(Letter)

Download/Full Text

Open Access version via Utrecht University Repository

Publisher version

Version on publisher website for UU-students and staff

Version on publisher website

Keywords: Journal Article

DOI: https://doi.org/10.1111/cea.14585

ISSN: 0954-7894

Publisher: Wiley-Blackwell

(Peer reviewed)